Medicine & Pharmaceuticals

Latest News Releases

*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

HeadlinesMore>>
iMD Companies Inc., Receives $500,000.00 Short Term Funding Commitment from Private Investment Group
iMD Companies Inc., Receives $500,000.00 Short Term Funding Commitment from Private Investment Group
TAMPA, FL, July 24, 2014 /PRNewswire/ - iMD Companies, Inc. (OTC:ICBU) iMD Companies is pleased to announce that a group of accredited investors has signed an agreement to invest up to $500,000.00 specifically targeted at...More >>
TAMPA, FL, July 24, 2014 /PRNewswire/ - iMD Companies, Inc. (OTC:ICBU) iMD Companies is pleased to announce that a group of accredited investors has signed an agreement to invest up to $500,000.00 specifically targeted at...More >>
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2014 Financial Results
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2014 Financial Results
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2014 financial results and provide an update on the company's business and outlook...More >>
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2014 financial results and provide an update on the company's business and outlook...More >>
Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services
Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services
Restore Health, a leading personalized medicine company that provides specialty and compounded pharmaceuticals, announced that it is now offering pharmacogenetics testing that provides drug sensitivity information unique...More >>
Restore Health, a leading personalized medicine company that provides specialty and compounded pharmaceuticals, announced that it is now offering pharmacogenetics testing that provides drug sensitivity information unique...More >>
Endo completes acquisition of Grupo Farmaceutico Somar®
Endo completes acquisition of Grupo Farmaceutico Somar®
Advances Endo's transformation into a leading global specialty healthcare company Establishes a platform for growth in key Latin American emerging markets Norbert Oppitz appointed Regional President, Latin America,...More >>
Advances Endo's transformation into a leading global specialty healthcare company Establishes a platform for growth in key Latin American emerging markets Norbert Oppitz appointed Regional President, Latin America,...More >>
DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial
DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today that the company's board of directors approved a change of the company's fiscal year from December 31 to June 30. Accordingly,...More >>
DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today that the company's board of directors approved a change of the company's fiscal year from December 31 to June 30. Accordingly,...More >>
IRIDEX Announces Second Quarter 2014 Conference Call and Release Date
IRIDEX Announces Second Quarter 2014 Conference Call and Release Date
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its second quarter 2014 financial results after the market closes on Thursday, July 31, 2014. In conjunction with the release, the Company will host a...More >>
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its second quarter 2014 financial results after the market closes on Thursday, July 31, 2014. In conjunction with the release, the Company will host a...More >>
Mettler-Toledo International Inc. Reports Second Quarter 2014 Results
Mettler-Toledo International Inc. Reports Second Quarter 2014 Results
Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results for 2014. Provided below are the highlights:More >>
Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results for 2014. Provided below are the highlights:More >>
IGI Laboratories, Inc. Announces Change To Its Board Of Directors
IGI Laboratories, Inc. Announces Change To Its Board Of Directors
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has accepted Damian Finio's resignation from its Board of Directors. Mr. Finio has accepted a...More >>
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has accepted Damian Finio's resignation from its Board of Directors. Mr. Finio has accepted a...More >>
IGI Laboratories Announces Second Quarter 2014 Results
IGI Laboratories Announces Second Quarter 2014 Results
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic drug development and manufacturing company, announced its financial results for the second quarter ended June 30, 2014.More >>
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic drug development and manufacturing company, announced its financial results for the second quarter ended June 30, 2014.More >>
Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015
Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the first fiscal quarter ended June 30, 2014.More >>
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the first fiscal quarter ended June 30, 2014.More >>
Omnicell to Release Second Quarter 2014 Earnings Results on July 31
Omnicell to Release Second Quarter 2014 Earnings Results on July 31
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, July 31, to discuss the Company's...More >>
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, July 31, to discuss the Company's...More >>
Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2014
Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2014
Champions Oncology, Inc. (OTC: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the year...More >>
Champions Oncology, Inc. (OTC: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the year...More >>
Uroplasty Reports Fiscal First Quarter Results
Uroplasty Reports Fiscal First Quarter Results
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 first...More >>
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 first...More >>
Amgen Announces Webcast of 2014 Second Quarter Financial Results
Amgen Announces Webcast of 2014 Second Quarter Financial Results
Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 29, 2014, after the close of the U.S. financial markets. The announcement will be followed by a conference call...More >>
Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 29, 2014, after the close of the U.S. financial markets. The announcement will be followed by a conference call...More >>
QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline
QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline
Exclusive global license from University of Tokyo enables development of QIAGEN assays for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, for blood cancers Mutations of SF3B1 gene, to be targeted...More >>
Exclusive global license from University of Tokyo enables development of QIAGEN assays for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, for blood cancers Mutations of SF3B1 gene, to be targeted...More >>
Stem Cells In Sports Injuries, Joints And Muscular Pain
Stem Cells In Sports Injuries, Joints And Muscular Pain
Now available is a stem cell therapy that is incredibly close to home. Rehealth Regenerative Therapies, located in Guadalajara, Mexico, is offering athletes and other physically active people a new health option: stem cell...More >>
Now available is a stem cell therapy that is incredibly close to home. Rehealth Regenerative Therapies, located in Guadalajara, Mexico, is offering athletes and other physically active people a new health option: stem cell...More >>
Asterias Biotherapeutics Announces Live Investor Webcast
Asterias Biotherapeutics Announces Live Investor Webcast
Asterias Biotherapeutics, Inc. (OTCBB: ASTYV), a leading biotechnology company in the emerging field of regenerative medicine, announced today that it will host a live webcast of a presentation to investors on Tuesday,...More >>
Asterias Biotherapeutics, Inc. (OTCBB: ASTYV), a leading biotechnology company in the emerging field of regenerative medicine, announced today that it will host a live webcast of a presentation to investors on Tuesday,...More >>
BigAppleRx Saves Uninsured New Yorkers More Than $25 Million
BigAppleRx Saves Uninsured New Yorkers More Than $25 Million
Today the New York City Department of Health and Mental Hygiene marked the success of the city-wide BigAppleRx prescription discount card program. BigAppleRx has surpassed more than $25 million in savings for New Yorkers...More >>
Today the New York City Department of Health and Mental Hygiene marked the success of the city-wide BigAppleRx prescription discount card program. BigAppleRx has surpassed more than $25 million in savings for New Yorkers...More >>
Dental Supplies Online is Key to Dental Success...Really!
Dental Supplies Online is Key to Dental Success...Really!
Many new dentists who are opening their own offices often wonder what they can do to ensure that their practice will be a success. DentalDisposables.net is here to say that where dentists purchase the basic supplies they...More >>
Many new dentists who are opening their own offices often wonder what they can do to ensure that their practice will be a success. DentalDisposables.net is here to say that where dentists purchase the basic supplies they...More >>
ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
ECC West Africa, LLC (ECC) signed a contract in Denver, Colorado with University College Hospital (UCH) Ibadan Board of Management for the first phase of a development project to finance, design, construct, and operate and...More >>
ECC West Africa, LLC (ECC) signed a contract in Denver, Colorado with University College Hospital (UCH) Ibadan Board of Management for the first phase of a development project to finance, design, construct, and operate and...More >>
Surveyed U.S. and EU5 Dermatologists Indicate that Short-Term and Long-Term Effects on Psoriatic Plaque Clearance are Two Attributes that Most Strongly Influence Prescribing Decisions in Moderate to Severe Psoriasis
Surveyed U.S. and EU5 Dermatologists Indicate that Short-Term and Long-Term Effects on Psoriatic Plaque Clearance are Two Attributes that Most Strongly Influence Prescribing Decisions in Moderate to Severe Psoriasis
Decision Resources Group finds that, according to surveyed U.S. and EU5 dermatologists, short-term and long-term effects on psoriatic plaque clearance are two of the attributes that most strongly influence their...More >>
Decision Resources Group finds that, according to surveyed U.S. and EU5 dermatologists, short-term and long-term effects on psoriatic plaque clearance are two of the attributes that most strongly influence their...More >>
Alimera Sciences To Release Second Quarter 2014 Results
Alimera Sciences To Release Second Quarter 2014 Results
Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will...More >>
Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will...More >>
Tragic Death: CSACI Statement
Tragic Death: CSACI Statement
OTTAWA, July 24, 2014 The Canadian Society of Allergy and Clinical Immunology (CSACI) would like to comment on the death of Mrs. Lucie Roussel, Mayor of La Prairie, on Sunday. As previously reported, Mrs. Roussel stepped...More >>
OTTAWA, July 24, 2014 The Canadian Society of Allergy and Clinical Immunology (CSACI) would like to comment on the death of Mrs. Lucie Roussel, Mayor of La Prairie, on Sunday. As previously reported, Mrs. Roussel stepped...More >>
LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment
LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment
LSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences consulting company. Kineticos will support LSI Medience in identifying...More >>
LSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences consulting company. Kineticos will support LSI Medience in identifying...More >>
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy...More >>
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy...More >>
Parkinson's Disease Foundation Awards $1.3 Million in Research Grants to Help Solve, Treat and End Parkinson's Disease
Parkinson's Disease Foundation Awards $1.3 Million in Research Grants to Help Solve, Treat and End Parkinson's Disease
The Parkinson's Disease Foundation® (PDF®) is pleased to announce $1.3 million in funding for more than 30 investigator-initiated research projects to help solve, treat and end Parkinson's disease. Chosen through...More >>
The Parkinson's Disease Foundation® (PDF®) is pleased to announce $1.3 million in funding for more than 30 investigator-initiated research projects to help solve, treat and end Parkinson's disease. Chosen through...More >>
Legal Medical Marijuana Industry Goes Through Significant Changes as Progressive Regulatory Developments are Implemented - Company Aims to Take Advantage of Latest Developments
Legal Medical Marijuana Industry Goes Through Significant Changes as Progressive Regulatory Developments are Implemented - Company Aims to Take Advantage of Latest Developments
Cannabis and Legal Medical Marijuana companies adapt to latest industry developments with innovative operations and products to meet evolving expectations of both consumers and government regulations: OSL Holdings (OTC:...More >>
Cannabis and Legal Medical Marijuana companies adapt to latest industry developments with innovative operations and products to meet evolving expectations of both consumers and government regulations: OSL Holdings (OTC:...More >>
Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific
Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific
Research and Markets has announced the addition of the "Global Cell Culture Market 2014-2018" report to their offering.More >>
Research and Markets has announced the addition of the "Global Cell Culture Market 2014-2018" report to their offering.More >>
Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific
Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific
Research and Markets has announced the addition of the "Global Genomics and Proteomics Analytical Instruments Market 2014-2018" report to their offering.More >>
Research and Markets has announced the addition of the "Global Genomics and Proteomics Analytical Instruments Market 2014-2018" report to their offering.More >>
OSL Holdings' CEO Issues a Letter to Shareholders Updating Shareholders on Positive Changes in the Legal Medical Marijuana Industry
OSL Holdings' CEO Issues a Letter to Shareholders Updating Shareholders on Positive Changes in the Legal Medical Marijuana Industry
OSL Holdings (OTCQB: OSLH) ("OSL" or "the Company"), a socially conscious business model dedicated to consumer advocacy, social activism and the advancement of civil liberties through the power of commerce, today released...More >>
OSL Holdings (OTCQB: OSLH) ("OSL" or "the Company"), a socially conscious business model dedicated to consumer advocacy, social activism and the advancement of civil liberties through the power of commerce, today released...More >>
Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%
Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug Application (NDA) for...More >>
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug Application (NDA) for...More >>
GliaCure Appoints New Member to Board of Directors
GliaCure Appoints New Member to Board of Directors
GliaCure, Inc., a company focused on developing novel, non-neuronal therapies for a range of neurological and neuropsychiatric disorders, announced today that it has appointed Joseph S. Zakrzewski to the Company's...More >>
GliaCure, Inc., a company focused on developing novel, non-neuronal therapies for a range of neurological and neuropsychiatric disorders, announced today that it has appointed Joseph S. Zakrzewski to the Company's...More >>
Federal 'Innovations Exchange' Features N.J. Hospital Pilot Program
Federal 'Innovations Exchange' Features N.J. Hospital Pilot Program
A consortium of 12 New Jersey hospitals achieved $113 million in healthcare savings under a pilot project that encourages hospitals and physicians to work together to provide more efficient, high-quality care, according to...More >>
A consortium of 12 New Jersey hospitals achieved $113 million in healthcare savings under a pilot project that encourages hospitals and physicians to work together to provide more efficient, high-quality care, according to...More >>
CorMedix, Inc. Granted Extension of NYSE-MKT Listing
CorMedix, Inc. Granted Extension of NYSE-MKT Listing
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announces receipt of...More >>
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious disease, today announces receipt of...More >>
Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA)
Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA)
Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to...More >>
Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis. This is the Company's third IND to...More >>
Talyst Exhibits at the National Association of State Veterans Homes Summer Conference
Talyst Exhibits at the National Association of State Veterans Homes Summer Conference
Talyst, a market leader in pharmacy automation, will be exhibiting at the 2014 National Association of State Veterans Homes (NASVH) Summer Conference in Charleston, South Carolina. The goal of the NASVH is to ensure that...More >>
Talyst, a market leader in pharmacy automation, will be exhibiting at the 2014 National Association of State Veterans Homes (NASVH) Summer Conference in Charleston, South Carolina. The goal of the NASVH is to ensure that...More >>
National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS
National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS
SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to conduct preclinical...More >>
SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to conduct preclinical...More >>
Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key
Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key
The American Association for Homecare (AAHomecare) yesterday announced that Brightree is supporting its mission to help address audit issues in the HME industry through a new and exclusive agreement to be the information...More >>
The American Association for Homecare (AAHomecare) yesterday announced that Brightree is supporting its mission to help address audit issues in the HME industry through a new and exclusive agreement to be the information...More >>
Study Finds Pycnogenol® Effective In Improving Inner Ear Circulation With Relief Of Symptoms Of Meniere's Disease Including Tinnitus
Study Finds Pycnogenol® Effective In Improving Inner Ear Circulation With Relief Of Symptoms Of Meniere's Disease Including Tinnitus
A new study published in the June issue of the Minerva Medica found that supplementation with Pycnogenol® (pic-noj-en-all), a natural antioxidant plant extract from French maritime pine tree bark, significantly improves...More >>
A new study published in the June issue of the Minerva Medica found that supplementation with Pycnogenol® (pic-noj-en-all), a natural antioxidant plant extract from French maritime pine tree bark, significantly improves...More >>
Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma
Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma
Decision Resources Group finds that, for the treatment of asthma, pulmonologists in the EU5 countries (France, Germany, Italy, Spain and the United Kingdom) hold a generally positive view of the first once-daily...More >>
Decision Resources Group finds that, for the treatment of asthma, pulmonologists in the EU5 countries (France, Germany, Italy, Spain and the United Kingdom) hold a generally positive view of the first once-daily...More >>
Geisinger study: Overweight boys may benefit from living with adult who has bariatric surgery
Geisinger study: Overweight boys may benefit from living with adult who has bariatric surgery
A parent's bariatric surgery could be an opportunity to break the cycle of obesity in an overweight son – body mass index (BMI) of 85 to 94 – according to a Geisinger research study published in the July issue of...More >>
A parent's bariatric surgery could be an opportunity to break the cycle of obesity in an overweight son – body mass index (BMI) of 85 to 94 – according to a Geisinger research study published in the July issue of...More >>
Quality Innovation Network Contract Awarded to Support Medicare Quality Improvement in Minnesota, Michigan and Wisconsin
Quality Innovation Network Contract Awarded to Support Medicare Quality Improvement in Minnesota, Michigan and Wisconsin
The Centers for Medicare & Medicaid Services (CMS) has awarded a Quality Innovation Network - Quality Improvement Organization (QIN-QIO) contract to support its work improving health care for Medicare beneficiaries in...More >>
The Centers for Medicare & Medicaid Services (CMS) has awarded a Quality Innovation Network - Quality Improvement Organization (QIN-QIO) contract to support its work improving health care for Medicare beneficiaries in...More >>
Advanced Biologics publishes additional OsteoAMP® abstracts in The Bone and Joint Journal
Advanced Biologics publishes additional OsteoAMP® abstracts in The Bone and Joint Journal
Advanced Biologics, currently attending the NASS Summer Spine Meeting in Amelia Island, FL, announced today the publishing of two abstracts within The Bone and Joint Journal. Initially presented at the European...More >>
Advanced Biologics, currently attending the NASS Summer Spine Meeting in Amelia Island, FL, announced today the publishing of two abstracts within The Bone and Joint Journal. Initially presented at the European...More >>
Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15
Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15
Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights India Business grew by 20.87% to Rs. 3,971.59 MnUS Business grew by 9.33% to Rs. 4,886.70 MnRest of World (ROW) Business grew by 20.67%...More >>
Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights India Business grew by 20.87% to Rs. 3,971.59 MnUS Business grew by 9.33% to Rs. 4,886.70 MnRest of World (ROW) Business grew by 20.67%...More >>
Passport Health celebrates 20 years as the travel medicine industry leader
Passport Health celebrates 20 years as the travel medicine industry leader
This year, Passport Health, the largest and leading provider of travel medicine and immunization services in North America, celebrates its 20 year anniversary. The company was founded in 1994 by Fran Lessans, a Registered...More >>
This year, Passport Health, the largest and leading provider of travel medicine and immunization services in North America, celebrates its 20 year anniversary. The company was founded in 1994 by Fran Lessans, a Registered...More >>
Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020
Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020
Research and Markets has announced the addition of the "Machine Health Monitoring Market by Product, Component, Application and Geography - Global Forecast to 2014 - 2020" report to their offering.More >>
Research and Markets has announced the addition of the "Machine Health Monitoring Market by Product, Component, Application and Geography - Global Forecast to 2014 - 2020" report to their offering.More >>
Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology
Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced today that the United States Patent and Trademark Office has issued a new...More >>
Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced today that the United States Patent and Trademark Office has issued a new...More >>
Emergency Medical Products Announces Addition of CPR RsQ Assist® Device to Growing Product Line
Emergency Medical Products Announces Addition of CPR RsQ Assist® Device to Growing Product Line
Emergency Medical Products (EMP), a leading distributor of emergency medical equipment and supplies, announced the addition of CPR RsQ Assist® to its growing line of medical supplies and equipment.More >>
Emergency Medical Products (EMP), a leading distributor of emergency medical equipment and supplies, announced the addition of CPR RsQ Assist® to its growing line of medical supplies and equipment.More >>
Fast-Tracking the Global HIV Response - Day 5 at AIDS 2014
Fast-Tracking the Global HIV Response - Day 5 at AIDS 2014
Sir Bob Geldof Says the 'Last Mile' of the HIV Epidemic Must be Funded Sir Bob Geldof told delegates at AIDS 2014, the 20th International AIDS Conference, that the "preposterous reluctance" of governments to fund...More >>
Sir Bob Geldof Says the 'Last Mile' of the HIV Epidemic Must be Funded Sir Bob Geldof told delegates at AIDS 2014, the 20th International AIDS Conference, that the "preposterous reluctance" of governments to fund...More >>
Prevent Tipping Furniture From Injuring or Killing Young Children
Prevent Tipping Furniture From Injuring or Killing Young Children
The nation's emergency physicians handle tragic situations too often, but few things are more upsetting than the sudden death of a child - killed by a piece of a furniture, appliance or a television falling on them.More >>
The nation's emergency physicians handle tragic situations too often, but few things are more upsetting than the sudden death of a child - killed by a piece of a furniture, appliance or a television falling on them.More >>
In RadioMD Interview, Dr. John Crew Describes Successful New Treatment for Flesh-Eating Disease
In RadioMD Interview, Dr. John Crew Describes Successful New Treatment for Flesh-Eating Disease
The National Necrotizing Fasciitis Foundation (NNFF) today is calling attention to an interview on RadioMD with Dr. John Crew, Medical Director of the Advanced Wound Care Center at Seton Medical Center in Daly City,...More >>
The National Necrotizing Fasciitis Foundation (NNFF) today is calling attention to an interview on RadioMD with Dr. John Crew, Medical Director of the Advanced Wound Care Center at Seton Medical Center in Daly City,...More >>
Zecotek Display Systems and the Institute of Chemical Physics of the National Academy of Sciences Develop High-Performance Materials for use in 3D Printing
Zecotek Display Systems and the Institute of Chemical Physics of the National Academy of Sciences Develop High-Performance Materials for use in 3D Printing
SINGAPORE, July 24, 2014 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its...More >>
SINGAPORE, July 24, 2014 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its...More >>
Media Advisory: AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine
Media Advisory: AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine
What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or stop Parkinson's disease progression. The Michael J. Fox Foundation supported the...More >>
What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or stop Parkinson's disease progression. The Michael J. Fox Foundation supported the...More >>
UMD to Launch Graduate Certificate in Regulatory Science and Engineering This Fall
UMD to Launch Graduate Certificate in Regulatory Science and Engineering This Fall
The University of Maryland (UMD) Fischell Department of Bioengineering and UMD's Center of Excellence in Regulatory Science and Innovation (CERSI) will launch a new Graduate Certificate in Regulatory Science and...More >>
The University of Maryland (UMD) Fischell Department of Bioengineering and UMD's Center of Excellence in Regulatory Science and Innovation (CERSI) will launch a new Graduate Certificate in Regulatory Science and...More >>
Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs
Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs
Boston Children's Hospital's Global Pediatric Summit + Awards, Taking on Tomorrow (#PedInno14), will feature an "Innovation Tank" – a forum designed to give pediatric health care innovators an opportunity to pitch...More >>
Boston Children's Hospital's Global Pediatric Summit + Awards, Taking on Tomorrow (#PedInno14), will feature an "Innovation Tank" – a forum designed to give pediatric health care innovators an opportunity to pitch...More >>
Questcor Reports Record Second Quarter Financial Results
Questcor Reports Record Second Quarter Financial Results
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the second quarter ended June 30, 2014.More >>
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the second quarter ended June 30, 2014.More >>
e-MDs ranks 5th overall in Medscape EHR Report 2014
e-MDs ranks 5th overall in Medscape EHR Report 2014
e-MDs, a leading provider of electronic health records (EHRs) and practice management (PM) solutions, is ranked fifth overall in the Medscape EHR Report 2014 and in the top five in 13 other categories, the company...More >>
e-MDs, a leading provider of electronic health records (EHRs) and practice management (PM) solutions, is ranked fifth overall in the Medscape EHR Report 2014 and in the top five in 13 other categories, the company...More >>
Neogen comments on SenesTech
Neogen comments on SenesTech
Neogen Corporation (Nasdaq: NEOG) advised market analysts today that future forecasts of its potential revenue from new rodenticide research are premature. In its regular quarterly conference call to investors and analysts...More >>
Neogen Corporation (Nasdaq: NEOG) advised market analysts today that future forecasts of its potential revenue from new rodenticide research are premature. In its regular quarterly conference call to investors and analysts...More >>
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium
Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium
Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations,...More >>
Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY), a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations,...More >>
Mesothelioma Compensation Center Warns Family Members Not to Discount Compensation Possibilities for Older Mesothelioma Victims
Mesothelioma Compensation Center Warns Family Members Not to Discount Compensation Possibilities for Older Mesothelioma Victims
The Mesothelioma Compensation Center knows that many diagnosed victims of mesothelioma, or their family members discount the compensation possibilities because of the age of the victim, and as they would like to explain...More >>
The Mesothelioma Compensation Center knows that many diagnosed victims of mesothelioma, or their family members discount the compensation possibilities because of the age of the victim, and as they would like to explain...More >>
Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals
Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals
In any given hospital in the country at any given time, one in 25 patients has at least one hospital-acquired infection, according to the Centers of Disease Control and Prevention. What's more, many of these infections...More >>
In any given hospital in the country at any given time, one in 25 patients has at least one hospital-acquired infection, according to the Centers of Disease Control and Prevention. What's more, many of these infections...More >>
'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership
'Women in Pharmacy' Program Seeks to Expand Pharmacy Ownership
As part of its ongoing effort to help women pharmacists become business owners, Cardinal Health will host its annual Pharmacy Ownership Boot Camp on July 26 as part of the company's Retail Business Conference in...More >>
As part of its ongoing effort to help women pharmacists become business owners, Cardinal Health will host its annual Pharmacy Ownership Boot Camp on July 26 as part of the company's Retail Business Conference in...More >>
The Female Health Company To Report Third Quarter Operating Results on Thursday, July 31, 2014
The Female Health Company To Report Third Quarter Operating Results on Thursday, July 31, 2014
The Female Health Company (NASDAQ-CM: FHCO), today announced that it will host an investor conference call to discuss its operating results for the third quarter and the first nine months of FY2014 on Thursday, July 31,...More >>
The Female Health Company (NASDAQ-CM: FHCO), today announced that it will host an investor conference call to discuss its operating results for the third quarter and the first nine months of FY2014 on Thursday, July 31,...More >>
Goldman Small Cap Research Issues Research Report on BioCorRx Inc.
Goldman Small Cap Research Issues Research Report on BioCorRx Inc.
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on BioCorRx, Inc. (OTCQB – BICX). The healthcare solutions...More >>
Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on BioCorRx, Inc. (OTCQB – BICX). The healthcare solutions...More >>
Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer
Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer
Blueprint Medicines (Blueprint), a leader in discovering highly selective kinase inhibitors for genomically defined cancer patients, today announced the appointment of Jeffrey Albers as chief executive officer (CEO). Mr....More >>
Blueprint Medicines (Blueprint), a leader in discovering highly selective kinase inhibitors for genomically defined cancer patients, today announced the appointment of Jeffrey Albers as chief executive officer (CEO). Mr....More >>
CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million
CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million
Second Quarter and Recent Highlights: Appointed Pat Mackin as President and Chief Executive Officer effective September 2, 2014 Product revenues grew 12 percent year-over-year to $20.4 million BioGlue® revenues grew 14...More >>
Second Quarter and Recent Highlights: Appointed Pat Mackin as President and Chief Executive Officer effective September 2, 2014 Product revenues grew 12 percent year-over-year to $20.4 million BioGlue® revenues grew 14...More >>
WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division
WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division
WIRB-Copernicus Group® ("WCG")™, the world's largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division of Richmond,...More >>
WIRB-Copernicus Group® ("WCG")™, the world's largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division of Richmond,...More >>
Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology
Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology
Bruin Biometrics (BBI), a pioneer in biometric-sensor based medical devices, announced today that after two weeks of clinical briefings to over 200 pressure ulcer experts throughout the European Union, it gained...More >>
Bruin Biometrics (BBI), a pioneer in biometric-sensor based medical devices, announced today that after two weeks of clinical briefings to over 200 pressure ulcer experts throughout the European Union, it gained...More >>
Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland
Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland
Cancer patients in the west of Scotland will gain access to state-of-the-art cancer treatment closer to home when a new radiotherapy center opens near Glasgow next year. Varian Medical Systems (NYSE: VAR) has been selected...More >>
Cancer patients in the west of Scotland will gain access to state-of-the-art cancer treatment closer to home when a new radiotherapy center opens near Glasgow next year. Varian Medical Systems (NYSE: VAR) has been selected...More >>
Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer
Celsion Announces Positive Interim Data Update from its Phase 2 DIGNITY Study in Breast Cancer
Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in Recurrent Chest Wall Breast Cancer (RCWBC). The trial is designed to enroll 20...More >>
Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in Recurrent Chest Wall Breast Cancer (RCWBC). The trial is designed to enroll 20...More >>
Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system
Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system
Royal Philips (NYSE: PHG AEX: PHIA) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative ultra mobile ultrasound system, VISIQ, in the U.S. VISIQ is the...More >>
Royal Philips (NYSE: PHG AEX: PHIA) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative ultra mobile ultrasound system, VISIQ, in the U.S. VISIQ is the...More >>
Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP
Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported interim results in a Phase 2a single-arm, open-label trial where ASONEP™ is being investigated as a treatment for...More >>
Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported interim results in a Phase 2a single-arm, open-label trial where ASONEP™ is being investigated as a treatment for...More >>
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements
Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE:...More >>
Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE:...More >>
Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call
Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will...More >>
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will...More >>
Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea
Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea
Bayer HealthCare today announced positive results from a Phase III trial that evaluated a 15% foam formulation of its compound azelaic acid (AzA) for the topical treatment of inflammatory papules and pustules of rosacea....More >>
Bayer HealthCare today announced positive results from a Phase III trial that evaluated a 15% foam formulation of its compound azelaic acid (AzA) for the topical treatment of inflammatory papules and pustules of rosacea....More >>
New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent
New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent
To help health care organizations better understand trends in the cardiovascular market that could impact patient care and the bottom line, Novation released its Spring 2014 CV Watch, "Innovations in Cardiovascular Devices."More >>
To help health care organizations better understand trends in the cardiovascular market that could impact patient care and the bottom line, Novation released its Spring 2014 CV Watch, "Innovations in Cardiovascular Devices."More >>
Abbott Introduces New Similac® Breastfeeding Supplement with DHA, Lutein and Vitamin E
Abbott Introduces New Similac® Breastfeeding Supplement with DHA, Lutein and Vitamin E
Nutrition needs are greater when breastfeeding than any other time in a woman's life, including pregnancy, yet new research reveals diet alone may not be enough to meet the high nutritional needs during this important...More >>
Nutrition needs are greater when breastfeeding than any other time in a woman's life, including pregnancy, yet new research reveals diet alone may not be enough to meet the high nutritional needs during this important...More >>
Misonix, Inc. Enhances its Digital Presence with the Unveiling of its New BoneScalpel™ App
Misonix, Inc. Enhances its Digital Presence with the Unveiling of its New BoneScalpel™ App
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound...More >>
Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound...More >>
Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results
Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results
Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today reported financial results for the quarter ended June 30, 2014. The Company reported second quarter net sales of $1.18 billion, an increase of 1.2% reported and 0.9%...More >>
Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today reported financial results for the quarter ended June 30, 2014. The Company reported second quarter net sales of $1.18 billion, an increase of 1.2% reported and 0.9%...More >>
Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance
Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance
MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to...More >>
MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to...More >>
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40.
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40.
HIGHLIGHTS: Q2 2014 Results (all percentage changes are against the same period in 2013) Reported sales increased 3% to $701 million. Sales grew organically by 2%, and changes in foreign currency exchange rates added one...More >>
HIGHLIGHTS: Q2 2014 Results (all percentage changes are against the same period in 2013) Reported sales increased 3% to $701 million. Sales grew organically by 2%, and changes in foreign currency exchange rates added one...More >>
MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe
MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe
Market Diagnostics International LLC ("MDxI") today announced the availability of IVD Insights™ LabFile, a data resource that sets a new standard for defining the US clinical laboratory universe and identifying target In...More >>
Market Diagnostics International LLC ("MDxI") today announced the availability of IVD Insights™ LabFile, a data resource that sets a new standard for defining the US clinical laboratory universe and identifying target In...More >>
WHEATON® Highlights Products at AACC 2014 Offering Unique Solutions for the Clinical Market
WHEATON® Highlights Products at AACC 2014 Offering Unique Solutions for the Clinical Market
WHEATON® today highlighted products to be featured at the 2014 AACC Annual Meeting that provide unique solutions addressing the specific needs of clinical laboratory and other clinical life sciences customers. These...More >>
WHEATON® today highlighted products to be featured at the 2014 AACC Annual Meeting that provide unique solutions addressing the specific needs of clinical laboratory and other clinical life sciences customers. These...More >>
Quest Diagnostics Reports Second Quarter 2014 Financial Results
Quest Diagnostics Reports Second Quarter 2014 Financial Results
Boston Scientific Announces Results For Second Quarter Ended June 30, 2014
Boston Scientific Announces Results For Second Quarter Ended June 30, 2014
Boston Scientific Corporation (NYSE: BSX) generated sales of $1.873 billion during the second quarter ended June 30, 2014, compared to the company's guidance range for the quarter of $1.840 to $1.890 billion. This...More >>
Boston Scientific Corporation (NYSE: BSX) generated sales of $1.873 billion during the second quarter ended June 30, 2014, compared to the company's guidance range for the quarter of $1.840 to $1.890 billion. This...More >>
West To Host Second Quarter 2014 Conference Call
West To Host Second Quarter 2014 Conference Call
West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release second quarter 2014 financial results before the market opens on Thursday, July 31, 2014 and will follow with a conference call to discuss...More >>
West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release second quarter 2014 financial results before the market opens on Thursday, July 31, 2014 and will follow with a conference call to discuss...More >>
OncoGenex to Report Financial Results for Second Quarter 2014 on August 7, 2014
OncoGenex to Report Financial Results for Second Quarter 2014 on August 7, 2014
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's second quarter 2014 financial results will be released on Thursday, August 7, 2014, and that the Company will host a conference call and...More >>
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's second quarter 2014 financial results will be released on Thursday, August 7, 2014, and that the Company will host a conference call and...More >>
Lilly Reports Second-Quarter 2014 Results
Lilly Reports Second-Quarter 2014 Results
Second-quarter 2014 revenue declined 17 percent driven by the impact of U.S. patent expirations for Cymbalta and Evista, partially offset by volume growth in several other products. Expense management initiatives resulted...More >>
Second-quarter 2014 revenue declined 17 percent driven by the impact of U.S. patent expirations for Cymbalta and Evista, partially offset by volume growth in several other products. Expense management initiatives resulted...More >>
Spherix Schedules Shareholder Update Call
Spherix Schedules Shareholder Update Call
Spherix Incorporated (NASDAQ:SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the Company will issue a business update for the...More >>
Spherix Incorporated (SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the Company will issue a business update for the period...More >>
TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform
TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform
Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a...More >>
Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a...More >>
EasyOne Pro from ndd Medical Technologies Chosen Again as the Exclusive PFT Testing Technology in Phase 2 of COPDGene Study
EasyOne Pro from ndd Medical Technologies Chosen Again as the Exclusive PFT Testing Technology in Phase 2 of COPDGene Study
ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro® has been chosen as the instrument to measure Carbon Monoxide...More >>
ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro® has been chosen as the instrument to measure Carbon Monoxide...More >>
Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery
Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery
Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine...More >>
Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine...More >>
Lawsuit Settlement News Website Reports DePuy ASR $2.5 Billion Hip Litigation Settlement, However Many Cases Remain Ongoing
Lawsuit Settlement News Website Reports DePuy ASR $2.5 Billion Hip Litigation Settlement, However Many Cases Remain Ongoing
MT Services LLC, The Lawsuit Settlement News Reporting company, which operates a lawsuit help center: lawsuitsettlementnews.com, reports today Johnson & Johnson's $2.5 billion lawsuit settlement was for an...More >>
MT Services LLC, The Lawsuit Settlement News Reporting company, which operates a lawsuit help center: lawsuitsettlementnews.com, reports today Johnson & Johnson's $2.5 billion lawsuit settlement was for an...More >>
Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin
Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin
Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company"), announced a collaboration to...More >>
Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company"), announced a collaboration to...More >>
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)
Announced at the 20th International AIDS Conference in Melbourne, the agreement seeks to increase access to a promising new HIV medicine in 112 developing countries At the AIDS 2014 conference in Melbourne today, the...More >>
Announced at the 20th International AIDS Conference in Melbourne, the agreement seeks to increase access to a promising new HIV medicine in 112 developing countries At the AIDS 2014 conference in Melbourne today, the...More >>
Pfenex Inc. Announces Pricing Of Initial Public Offering
Pfenex Inc. Announces Pricing Of Initial Public Offering
Pfenex Inc. (NYSE MKT: PFNX) today announced the pricing of its initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share. In addition, Pfenex has granted the underwriters...More >>
Pfenex Inc. (NYSE MKT: PFNX) today announced the pricing of its initial public offering of 8,333,333 shares of its common stock at a price to the public of $6.00 per share. In addition, Pfenex has granted the underwriters...More >>
Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw to Executive Officer
Sysmex Corporation Appoints U.S. Subsidiary CEO John Kershaw to Executive Officer
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of...More >>
Sysmex America, Inc., the United States subsidiary for Sysmex Corporation, Kobe, Japan, announced that the company's President and Chief Executive Officer, John Kershaw, has been appointed an Executive Officer of...More >>
An Expert Civil Surgeon at Santa Monica Pediatrics and Adult Medicine can Make all the Difference
An Expert Civil Surgeon at Santa Monica Pediatrics and Adult Medicine can Make all the Difference
As a growing number of individuals and families seek new opportunities in the U.S., they'll face a number of hurdles along the way. That's why they can take heart in knowing they'll find a caring and highly...More >>
As a growing number of individuals and families seek new opportunities in the U.S., they'll face a number of hurdles along the way. That's why they can take heart in knowing they'll find a caring and highly...More >>
Boston Scientific Receives CE Mark For Agent™ Drug-Coated Balloon
Boston Scientific Receives CE Mark For Agent™ Drug-Coated Balloon
Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European market launch of the Agent™...More >>
Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European market launch of the Agent™...More >>
Streamline Health® to Announce First Quarter 2014 Financial Results July 24, 2014
Streamline Health® to Announce First Quarter 2014 Financial Results July 24, 2014
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance,...More >>
Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance,...More >>

PR Newswire IndexMore>>
Entertainment News Releases via PRNewswire
Entertainment
Entertainment News Releases via PRNewswire
Travel
Travel News Releases via PRNewswire
Political Campaigns
Political Campaigns News Releases via PRNewswire
Medicine & Pharmaceuticals
Medicine & Pharmaceuticals News Releases via PRNewswire
Film & Motion Picture News Releases via PRNewswire
Film & Motion Picture
Film & Motion Picture News Releases via PRNewswire
Economic News and Analysis
Economic News Releases via PRNewswire
Computer Software
Computer Software News Releases via PRNewswire
Computer Networks
Computer Networks News Releases via PRNewswire
Computer Hardware
Computer Hardware News Releases via PRNewswire
Biotech News Releases via PRNewswire
Biotechnology
Biotechnology News Releases via PRNewswire

ABC6 ExtraMore>>
Big Deal
Big Deal
Click here to get 1/2 off gift certificates!More >>
Get Half-Priced Gift Certificates!More >>
Contests
Contests
Click here to see our ABC6 Contests page!More >>
Click here to see our ABC6 Contests page!More >>
Lottery
Lottery
Is today your lucky day? Click here to get the daily numbers.More >>
Horoscopes
Horoscopes
Daily horoscopes for life, love, work and more!More >>
Green Living
Green Living
Find latest environmental news, tips and information for staying green.More >>
Pets
Pets
Learn more tips for caring for, grooming and training your favorite pet.More >>

Medicine & Pharmaceuticals - ABC6 - Providence, RI and New Bedford, MA News, Weather

HeadlinesMore>>